SMTL ID : 5mzj.1

Crystal structure of stabilized A2A adenosine receptor A2AR-StaR2-bRIL in complex with theophylline at 2.0A resolution

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.00 Å

Oligo State

monomer

Ligands

1 x NA: SODIUM ION(Non-functional Binders)

NA.1: 3 residues within 4Å: Chain A: D.62, S.101, N.386 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:D.62, A:S.101 Water bridges: A:D.62

1 x TEP: THEOPHYLLINE(Non-covalent)

TEP.2: 8 residues within 4Å: Chain A: L.95, F.178, E.179, M.187, L.355, N.359, M.376, I.380 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:N.359, A:N.359 pi-Stacking: A:F.178, A:F.178

3 x CLR: CHOLESTEROL(Non-covalent)

CLR.3: 8 residues within 4Å: Chain A: F.72, A.82, A.83, G.86, F.89, I.90 Ligands: OLA.27, OLC.31 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:F.72, A:F.72, A:A.82, A:F.89, A:I.90, A:I.90 Hydrogen bonds: A:A.83 Water bridges: A:Q.173, A:Q.173 CLR.4: 12 residues within 4Å: Chain A: L.350, L.353, P.354, I.357, I.358, F.361, C.368, S.369, A.371, L.375 Ligands: OLA.11, OLA.22 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:L.350, A:L.353, A:P.354, A:I.357, A:I.358, A:F.361, A:L.375 Hydrogen bonds: A:S.369 CLR.5: 7 residues within 4Å: Chain A: L.197, I.357, C.360, F.361, F.364, C.365 Ligands: OLC.28 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:L.197, A:I.357, A:F.361, A:F.361, A:F.361, A:F.364 Water bridges: A:F.364

22 x OLA: OLEIC ACID(Non-covalent)(Non-functional Binders)

OLA.6: 9 residues within 4Å: Chain A: V.67, P.71, I.74, T.75, T.78, F.80 Ligands: OLA.14, OLC.30, OLC.31 Ligand excluded by PLIP OLA.7: 3 residues within 4Å: Chain A: G.205, L.208, R.209 Ligand excluded by PLIP OLA.8: 6 residues within 4Å: Chain A: F.54, F.103, A.107, D.111, V.126, I.134 Ligand excluded by PLIP OLA.9: 5 residues within 4Å: Chain A: G.15, V.18, Y.377, V.381 Ligands: OLA.18 Ligand excluded by PLIP OLA.10: 3 residues within 4Å: Chain A: I.137, L.141 Ligands: OLA.17 Ligand excluded by PLIP OLA.11: 4 residues within 4Å: Chain A: H.370, P.372, L.378 Ligands: CLR.4 Ligand excluded by PLIP OLA.12: 4 residues within 4Å: Chain A: L.29, G.33, V.35, F.392 Ligand excluded by PLIP OLA.13: 1 residues within 4Å: Chain A: W.374 Ligand excluded by PLIP OLA.14: 3 residues within 4Å: Ligands: OLA.6, OLC.29, OLC.30 Ligand excluded by PLIP OLA.15: 5 residues within 4Å: Chain A: S.17, I.20, T.21, L.24 Ligands: OLC.29 Ligand excluded by PLIP OLA.16: 5 residues within 4Å: Chain A: V.35, C.38, W.39, W.42 Ligands: OLC.33 Ligand excluded by PLIP OLA.17: 8 residues within 4Å: Chain A: R.130, G.133, I.137, V.140, L.141, A.144 Ligands: OLA.10, OLC.34 Ligand excluded by PLIP OLA.18: 8 residues within 4Å: Chain A: I.26, L.29, T.385, V.388, V.389, F.392 Ligands: OLA.9, OLA.19 Ligand excluded by PLIP OLA.19: 3 residues within 4Å: Chain A: I.393, Y.396 Ligands: OLA.18 Ligand excluded by PLIP OLA.20: 6 residues within 4Å: Chain A: L.200, L.204, Y.207, F.211, A.342, A.345 Ligand excluded by PLIP OLA.21: 3 residues within 4Å: Chain A: A.342, I.343, G.346 Ligand excluded by PLIP OLA.22: 7 residues within 4Å: Chain A: L.350, P.354, L.375, L.378, A.379, L.382 Ligands: CLR.4 Ligand excluded by PLIP OLA.23: 5 residues within 4Å: Chain A: F.143 Ligands: OLA.25, OLA.26, OLA.27, OLC.32 Ligand excluded by PLIP OLA.24: 4 residues within 4Å: Chain A: Y.189, F.193, F.364 Ligands: OLC.28 Ligand excluded by PLIP OLA.25: 6 residues within 4Å: Chain A: A.132, A.136, F.143 Ligands: OLA.23, OLA.26, OLC.32 Ligand excluded by PLIP OLA.26: 7 residues within 4Å: Chain A: H.85, M.150, L.151 Ligands: OLA.23, OLA.25, OLA.27, OLC.34 Ligand excluded by PLIP OLA.27: 6 residues within 4Å: Chain A: A.83, H.85, G.86 Ligands: CLR.3, OLA.23, OLA.26 Ligand excluded by PLIP

7 x OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate(Non-covalent)(Non-functional Binders)

OLC.28: 4 residues within 4Å: Chain A: L.197, F.364 Ligands: CLR.5, OLA.24 3 PLIP interactions: 3 interactions with chain A Hydrophobic interactions: A:L.197, A:F.364, A:F.364 OLC.29: 7 residues within 4Å: Chain A: S.16, I.20, L.24, S.77, T.78 Ligands: OLA.14, OLA.15 5 PLIP interactions: 5 interactions with chain A Hydrophobic interactions: A:I.20, A:L.24, A:T.78 Water bridges: A:P.12, A:Y.377 OLC.30: 3 residues within 4Å: Ligands: OLA.6, OLA.14, OLC.31 No protein-ligand interaction detected (PLIP) OLC.31: 11 residues within 4Å: Chain A: V.67, L.68, P.71, F.72, T.75, F.80, C.81, Q.173 Ligands: CLR.3, OLA.6, OLC.30 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:V.67, A:L.68, A:P.71, A:F.72, A:F.80, A:F.80 Hydrogen bonds: A:C.81, A:C.81, A:Q.173 OLC.32: 11 residues within 4Å: Chain A: Y.53, V.56, S.57, A.60, G.128, A.132, I.135, W.139, F.143 Ligands: OLA.23, OLA.25 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:V.56, A:A.60, A:I.135, A:I.135, A:W.139, A:W.139, A:W.139, A:F.143 Hydrogen bonds: A:G.128 OLC.33: 8 residues within 4Å: Chain A: C.38, V.41, W.42, Y.53, V.56, A.60, L.64 Ligands: OLA.16 4 PLIP interactions: 4 interactions with chain A Hydrophobic interactions: A:W.42, A:V.56, A:A.60, A:L.64 OLC.34: 7 residues within 4Å: Chain A: H.85, M.150, L.151, G.152, N.154 Ligands: OLA.17, OLA.26 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:N.154

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Cheng, R.K.Y. et al., Structures of Human A1 and A2A Adenosine Receptors with Xanthines Reveal Determinants of Selectivity. Structure (2017)

Release Date

2017-07-26

Peptides

Adenosine receptor A2a,Soluble cytochrome b562,Adenosine receptor A2a: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Membrane

We predict this structure to be a membrane protein.
Show / Hide

Adenosine receptor A2a,Soluble cytochrome b562,Adenosine receptor A2a

Related Entries With Identical Sequence